Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877485 · ClinicalTrials.gov registry record · Phase 4
The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 42
- Enrollment target
NCT02877485: Completed Phase 4 study, sponsored by Stanford University.
NCT02877485 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02877485, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this project is to determine if intranasal corticosteroids have an effect on nasal obstruction in patients with nasal septal deviation.
Interventions
- DRUG Triamcinolone Acetonide
- DRUG Ayr saline nasal mist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-08-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02877485
The ClinicalTrials.gov registry entry for NCT02877485 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Triamcinolone Acetonide is the first listed.
NCT02877485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02877485 about?
NCT02877485 is a clinical study titled "The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation". The purpose of this project is to determine if intranasal corticosteroids have an effect on nasal obstruction in patients with nasal septal deviation.
What is the current status of trial NCT02877485?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 42 participants. The study started on 2016-08. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT02877485?
The interventions under investigation include: Triamcinolone Acetonide (DRUG), Ayr saline nasal mist (DRUG).
Who is sponsoring clinical trial NCT02877485?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.